Table 1. Potentially life-threatening diseases: symptoms and incidences.
Disease | Symptoms | Incidence |
Delayed uterine atony(> 24 h postpartum) |
Signs of poor uterine involution (uterine subinvolution): Increased uterine height (abdominal palpation), soft-doughy uterus, pain at the uterine border, possible subfebrile temperature, frontal headache, intermittent, persistent, possibly increasing bleeding Also additional severe bleeding, possibly symptoms of shock |
Atonic bleeding (postpartum overall): 2.5%; 95% CI: [2.32; 2.62] (36) Delayed uterine atony (> 24 h postpartum): 0.2–2.5% (industrialized countries) (e93– e96) |
Endomyometritis(chorioamnionitis and sepsis) | Fever, tachycardia, lower abdominal pain, relatively soft uterus that is painful on palpation, foul-smelling lochia, general feeling of being unwell, increased leukocytes (e29) | Chorionamnionitis 3.9% (8) Endomyometritis 1.6–1.9% (8, e97) Sepsis 0.05% (8) |
Group A streptococcal sepsis | Acute disease course, usually within the first 48 h postpartum: high fever (in 73%), diffuse abdominal pain, putrid vaginal discharge, uterine tenderness, fever, chills, increased leukocytes, thrombocytopenia, hypotension (15) | 6/100,000 Births (14) |
Pre-eclampsia (modified from [4]) | Blood pressure > 140/90 mm Hg Headache, photopsia/impaired vision, upper abdominal pain, nausea/vomiting, general malaise, weight gain Impairment to: kidneys, liver, CNS, hematological or respiratory system, IUGR or placental insufficiency |
Hypertensive disorders (overall) 5–10% (e98) Pre-eclampsia ca. 4.6% Eclampsia ca. 1.4% (e97) Of which: Eclampsia 11–44% HELLP 7–30% (e100, e101) are postpartum (in relation to eclampsia/HELLP overall) |
Eclampsia | Additional tonic-clonic seizures | |
HELLP syndrome | Upper abdominal pain, nausea, vomiting, hemolysis, elevated liver enzymes, thrombocytopenia | |
Thrombosis/embolism | As in outside of pregnancy/puerperium Cave: misclassification as physiological symptoms of the puerperium |
Thrombosis 0.05–0.3% (23, 24) Embolism 0.08/1000 births (postpartum) (27) and 0.14/1000 (28) to 0.45/1000 (pre- and postpartum) (31) Pulmonary embolism 60.5 (28) to 61.3% postpartum (31) |
Sheehan’s syndrome | Hypopituitarism: (reduced lactation, amenorrhea, genital and axillary hair loss, asthenia and weakness, premature skin aging, dry skin, and hypopigmentation) | See Table 2 |
IUGR, intrauterine growth restriction; CNS, central nervous system; 95% CI, 95% confidence interval